India

Nasal Covid vaccine since the end of January by 800; 325 for the government

The world’s first nasal vaccine against Covid-19 will be launched through Bharat Biotech International in the fourth week of January 2023. The vaccine, iNCOVACC, was sold at a price of 800′ for the private market and 325′ for the public market. The vaccine is now available on CoWin and will be distributed as a booster dose for those who [. . . ]

Nasal Covid vaccine since the end of January by 800; 325 for the government Read More »

Biological E gets green light for phase III trial of its COVID-19 vaccine candidate

Biological E. Limited (BE) announced on Saturday that it has effectively completed Phase I/II clinical trials of its COVID-19 subunit vaccine candidate in India and obtained approval to commence the Phase III clinical trial from the Central Organization for Standard Control of Medicines (CDSCO) – Committee of Subject Matter Experts (SEC).

Biological E gets green light for phase III trial of its COVID-19 vaccine candidate Read More »